Analysts Boost Forecasts on Intuitive Surgical Following Strong Q4 Results

Intuitive Surgical (ISRG) stock has been on a roll following its strong fourth-quarter earnings report, with analysts increasing their price targets and ratings. The medical device maker reported revenue of $2.41 billion, a 25% jump year-over-year, and earnings of $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. The company also announced that it expects da Vinci procedures to grow 13% to 16% in 2025, which is in line with analysts' projections of 17.1% procedure growth for the year.

Analysts have taken note of Intuitive Surgical's strong performance and have increased their average target price for ISRG stock to $558.78, with a low estimate of $375 and a high estimate of $711. The average target predicts a decrease of -4.60% from the current stock price of $585.75. The analysts' consensus is a "Strong Buy" rating, indicating that they believe the stock is likely to perform very well in the near future and significantly outperform the market.



Intuitive Surgical's strong Q4 results and positive outlook have led analysts to maintain their bullish stance on the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. Additionally, Intuitive Surgical's market penetration and addressable market potential indicate significant growth opportunities for the company.

In conclusion, Intuitive Surgical's strong Q4 results and positive outlook have led analysts to increase their price targets and ratings for the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. With a best-possible Composite Rating of 99, Intuitive Surgical stock is in the top 1% of all stocks in terms of fundamental and technical measures, according to IBD Digital. As Intuitive Surgical continues to execute on its growth strategy, investors can expect the company to deliver strong performance in the coming years.